Long-term treatment with temozolomide in malignant glioma
- 1 January 2014
- journal article
- case report
- Published by Elsevier BV in Journal of Clinical Neuroscience
- Vol. 21 (1), 121-123
- https://doi.org/10.1016/j.jocn.2013.03.039
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- Long-term adjuvant administration of temozolomide in patients with glioblastoma multiforme: experience of a single institutionZeitschrift für Krebsforschung und Klinische Onkologie, 2010
- Long-term use of temozolomide: Could you use temozolomide safely for life in gliomas?Journal of Clinical Neuroscience, 2009
- Temozolomide in malignant gliomas: current use and future targetsCancer Chemotherapy and Pharmacology, 2009
- Non-Hodgkin's Lymphoma in Patients With Glioma Treated With TemozolomideJournal of Clinical Oncology, 2008
- Safety and feasibility of long-term temozolomide treatment in patients with high-grade gliomaNeurology, 2007
- Treatment-related myelodysplasia/AML in a patient with a history of breast cancer and an oligodendroglioma treated with temozolomide: Case study and review of the literature1Neuro-Oncology, 2006
- Secondary Ph+ acute lymphoblastic leukemia after temozolomideAnnals of Hematology, 2005
- Radiotherapy plus Concomitant and Adjuvant Temozolomide for GlioblastomaThe New England Journal of Medicine, 2005